CVD risk prediction
Mediwhale has recently raised $13 million in Series C funding, which will also support its entry into the United States market.
A new big data-based predictive model developed in Hong Kong enables more dynamic monitoring of six common cardiovascular diseases by capturing near-real-time biological changes.